Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
暂无分享,去创建一个
[1] Javier Hernández,et al. Uncoupling of Proliferative Potential and Gain of Effector Function by CD8+ T Cells Responding to Self-Antigens , 2002, The Journal of experimental medicine.
[2] Pamela S. Ohashi,et al. T-cell signalling and autoimmunity: molecular mechanisms of disease , 2002, Nature Reviews Immunology.
[3] A. Jegerlehner,et al. Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1 , 2002, The Journal of Immunology.
[4] F. Lechner,et al. Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.
[5] G. Belz,et al. Cutting Edge: Precursor Frequency Affects the Helper Dependence of Cytotoxic T Cells1 , 2002, The Journal of Immunology.
[6] B. Beutler. Toll-like receptors: how they work and what they do , 2002, Current opinion in hematology.
[7] E. Pamer,et al. Priming of Memory But Not Effector CD8 T Cells by a Killed Bacterial Vaccine , 2001, Science.
[8] Javier Hernández,et al. Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen , 2001, The Journal of experimental medicine.
[9] R. Zinkernagel,et al. Regulation of the Immune Response by Antigen , 2001, Science.
[10] F. Sallusto,et al. Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.
[11] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[12] Stephen P. Schoenberger,et al. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.
[13] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[14] I. N. Crispe,et al. Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo. , 2000, Immunity.
[15] L. Nguyen,et al. Role of Antigen-Presenting Cells in Mediating Tolerance and Autoimmunity , 2000, The Journal of experimental medicine.
[16] D. Pardoll,et al. Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes , 2000, The Journal of experimental medicine.
[17] M. Bachmann,et al. The role of T-cell receptor dimerization in T-cell activation. , 1999, Immunology today.
[18] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[19] H. Bien,et al. Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40 , 1999, Nature Medicine.
[20] T. Schumacher,et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy , 1999, Nature Medicine.
[21] M. Bachmann,et al. CD8+ T Cells Mediate CD40-independent Maturation of Dendritic Cells In Vivo , 1999, The Journal of experimental medicine.
[22] J. Opferman,et al. Linear differentiation of cytotoxic effectors into memory T lymphocytes. , 1999, Science.
[23] Christine Zimmermann,et al. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences , 1999, European journal of immunology.
[24] M. Bachmann,et al. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection , 1999, European journal of immunology.
[25] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[26] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[27] S Oehen,et al. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.
[28] Chyung-Ru Wang,et al. Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.
[29] R. Dubose,et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.
[30] R. Zinkernagel,et al. Peptide‐induced T cell receptor down‐regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation , 1997, European journal of immunology.
[31] D. Hanahan,et al. Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy , 1997, The Journal of experimental medicine.
[32] C. Kurts,et al. Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells , 1997, The Journal of experimental medicine.
[33] R. Zinkernagel,et al. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] H. Pircher,et al. On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Schuler,et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.
[36] A. Lanzavecchia,et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.
[37] R. Germain,et al. Partial signaling by CD8+ T cells in response to antagonist ligands , 1996, The Journal of experimental medicine.
[38] R. Offringa,et al. Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. , 1996, Journal of immunology.
[39] H. Pircher,et al. T cell priming versus T cell tolerance induced by synthetic peptides , 1995, The Journal of experimental medicine.
[40] R. Zinkernagel,et al. Induction of protective cytotoxic T cells with viral proteins , 1994, European journal of immunology.
[41] Hans Hengartner,et al. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides , 1993, European journal of immunology.
[42] R. Zinkernagel,et al. Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus , 1993, Journal of virology.
[43] P. Allen,et al. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. , 1993, Journal of immunology.
[44] R M Zinkernagel,et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.
[45] P. Allen,et al. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.
[46] H. Pircher,et al. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.
[47] M. Merkenschlager,et al. Memory T cells , 1989, Nature.
[48] R. Germain,et al. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. , 1999, Annual review of immunology.
[49] J. Altman,et al. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. , 1998, Advances in experimental medicine and biology.
[50] P. Allen,et al. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.
[51] M. Bevan,et al. T cell receptor antagonists and partial agonists. , 1995, Immunity.
[52] M. Battegay. [Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates] , 1993, ALTEX.
[53] M. Buchmeier,et al. Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. , 1985, British medical bulletin.
[54] F. Lehmann-Grube. Portraits of viruses: arenaviruses. , 1984, Intervirology.